Filing Details

Accession Number:
0001235802-21-000128
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-12 19:40:01
Reporting Period:
2021-10-01
Accepted Time:
2021-10-12 19:40:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427570 Reshape Lifesciences Inc. RSLS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1181166 Thomas Stankovich 1001 Calle Amanecer
San Clemente CA 92673
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Disposition 2021-10-01 3,660 $2.76 354,331 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were sold to cover taxes in connection with the vesting of restricted stock units.